[Clinical evaluation of tumor-associated trypsin inhibitor (TATI) in benign and malignant gynecological tumor].
Shigemasa
K
K
Department of Gynecology, National Shikoku Cancer Center Hospital, Matsuyama.
Hiura
M
M
Ioka
A
A
Yokoyama
T
T
Nogawa
T
T
Chiba
T
T
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D003937:Diagnosis, Differential; D005260:Female; D005833:Genital Neoplasms, Female / Q000175:diagnosis*; D006801:Humans; D011863:Radioimmunoassay / Q000379:methods; D011933:Reagent Kits, Diagnostic; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000032:analysis*
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; D011933:Reagent Kits, Diagnostic; D014359:Trypsin Inhibitor, Kazal Pancreatic